Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00782886
What this trial is testing

Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer

Who this might be right for
Liver Cancer
Pathfinder Therapeutics 75
Early research (Phase 1)UnknownNCT05643417
What this trial is testing

Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy

Who this might be right for
Metastatic Liver Cancer
Fudan University 80
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)WithdrawnNCT06902246
What this trial is testing

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
University of Miami
Testing effectiveness (Phase 2)WithdrawnNCT03307603
What this trial is testing

Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Case Comprehensive Cancer Center
Not applicableStudy completedNCT01904942
What this trial is testing

Study of Hepatocellular Carcinoma in Cirrhotic Patients

Who this might be right for
Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 600
Not applicableUnknownNCT04773769
What this trial is testing

Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionHepatocellular Carcinoma+3 more
Auxilio Mutuo Cancer Center 54
Not applicableNot Yet RecruitingNCT07368023
What this trial is testing

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
Ningbo Medical Center Lihuili Hospital 300
Post-approval studies (Phase 4)Study completedNCT02081469
What this trial is testing

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Who this might be right for
Hepatitis B, ChronicTumor
Chang Gung Memorial Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07483359
What this trial is testing

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04172779
What this trial is testing

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, LiverAdvanced Liver Fibrosis
University of Texas Southwestern Medical Center 60
Large-scale testing (Phase 3)Looking for participantsNCT06007846
What this trial is testing

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Inova Health Care Services 12
Testing effectiveness (Phase 2)UnknownNCT06375486
What this trial is testing

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma(uHCC).

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT04687280
What this trial is testing

Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Angers 153
Not applicableUnknownNCT06447727
What this trial is testing

Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

Who this might be right for
Colorectal Cancer Metastatic
Zhongda Hospital 30
Not applicableUnknownNCT03680183
What this trial is testing

Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

Who this might be right for
Non Small Cell Lung CancerHepatitis B
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 300
Not applicableStudy completedNCT00976898
What this trial is testing

Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma

Who this might be right for
Liver Cancer
Massachusetts General Hospital 83
Testing effectiveness (Phase 2)Study completedNCT01149304
What this trial is testing

Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity

Who this might be right for
Colorectal CancerLiver MetastasesIrradiation Damage+1 more
University of Magdeburg 22
Early research (Phase 1)Study completedNCT03256344
What this trial is testing

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

Who this might be right for
Metastatic Triple Negative Breast CancerMetastatic Colorectal Cancer
Amgen 36
Next Page